• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Infectious Disease

Low risk allergy symptoms not linked to true penicillin allergy

byKate AndersonandCordelia Ross
July 3, 2017
in Infectious Disease, Pediatrics
Reading Time: 3 mins read
Tonsillectomy may have short-term benefits in recurrent throat infection
Share on FacebookShare on TwitterShare on LinkedIn

1. 100% of children with low-risk symptoms such as rash and itching were negative for true penicillin allergies after 3-tier testing.

2. Rash and itching were reported to be the most common reactions misclassified as penicillin allergies by parents.

Evidence rating level: 4 (Below Average)

Study Rundown: Although penicillin is the most commonly reported medication allergy among the pediatric population, the majority of reported symptoms (rash, vomiting, diarrhea, etc.) are low-risk for true allergy. Having a penicillin allergy diagnosis alters physician antibiotic choice and may lead to suboptimal antibacterial therapy among children who present to the pediatric emergency department. In this study, researchers used a 3-tier testing processes to test for true allergy among 100 children with parent-reported, low-risk penicillin allergies. Results showed that the most commonly reported allergy symptom was rash, followed by itching. The majority of patients described initially having symptoms in relation to antibiotics used to treat an ear infection. Despite the diagnosis, all children tested were negative for true penicillin allergy. This study is limited in that symptoms were reported by parents, therefore the severity may have been misclassified. Also, selection bias may exist as not all eligible patients agreed to be tested. This study suggests using questionnaires to identify patients at low-risk for true penicillin allergies may reduce the need for time consuming and costly skin testing, and may aid in improving use of first-line antibiotic therapy for children in the pediatric ED setting.

Click to read the study, published today in Pediatrics

Relevant reading: The facts about penicillin allergy: a review

RELATED REPORTS

Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections

High maternal egg-peanut intake not associated with reduced infant allergy

In-depth [case series]: In this study, researchers identified children of ages of 3.5 to 18 years with a reported penicillin allergy who presented to an urban pediatric emergency department between April 2015 and November 2016. Parents were asked to fill out an allergy questionnaire that included questions on demographic information, allergy symptoms, and indication for antibiotics. From the 597 questionnaires completed, 434 (72.6%) were identified as having a low-risk allergy, and 302 were eligible for penicillin testing after chart review and symptom verification with the child’s primary care physician. Ultimately, 100 patients underwent the 3-tier allergy testing, which included a penicillin percutaneous test, an intracutaneous test, and finally an oral penicillin challenge. Only patients with no high-risk symptoms (e.g. any respiratory or cardiac symptoms) at 15 minutes were allowed to continue to the next tier. The median age of those tested was 9 years, while the median age of allergy diagnosis was 1 year. 60% were white, 20% were African American, and 11% were Hispanic. Rash was the most commonly reported symptom (97%), followed by itching (63%). Results showed that 100% of children with low-risk allergy symptoms tested in this analysis were negative for true penicillin allergies (95% CI 96.4%-100%). 75% of patients reported first noticing the allergy symptoms after being treated for ear infections, and 17% for throat infections. 92% of parents said the allergy was diagnosed by their child’s PCP, while conversations with 100% of the PCPs revealed that only 14% of cases had symptoms witnessed by a medical professional.

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: allergyantibioticantibiotic resistanceantibiotic-induced rashMedication Allergypenicillinrash
Previous Post

E-cigarette use linked to increased risk of cigarette smoking in adolescents and young adults

Next Post

Treatment of subclinical hypothyroidism ineffective in older adults

RelatedReports

A physician converses with a female patient, with elements suggesting technology and healthcare in the background.
Infectious Disease

Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections

October 9, 2026
A young boy stands beside various processed foods, while a taller teenager stands further along a winding path, symbolizing growth influenced by nutrition.
Chronic Disease

High maternal egg-peanut intake not associated with reduced infant allergy

September 22, 2026
USPSTF recommends routinely screening asymptomatic women for chlamydia and gonorrhea
Infectious Disease

Nuzolvence (Zoliflodacin) first oral Gonorrhea treatment shows non-inferior cure rates

January 14, 2026
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Cardiology

2 Minute Medicine: Pharma Roundup – New oral gonorrhea antibiotic Nuzolvence (zoliflodacin), late‑December cardiovascular and oncology drug approvals, first targeted complement inhibitor therapy for HSCT‑TMA (Yartemlea), and antibody‑drug conjugate (ADC) safety concerns with ifinatamab deruxtecan (I‑DXd) [January 2026]

January 26, 2026
Next Post
Treatment of subclinical hypothyroidism ineffective in older adults

Treatment of subclinical hypothyroidism ineffective in older adults

Aspirin therapy linked to fewer cases of preeclampsia

2 Minute Medicine Rewind July 3, 2017

Prescription of antibiotics for acute respiratory infections increasing

Clinical and biomarker-based diagnostic model identifies serious bacterial infections

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • An electronic health record tool for exercise prescription may reduce fall rate among older adults
  • Optogenetic therapy may partially restore vision in retinitis pigmentosa
  • An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.